Brief: Metagenomi Reports Business Updates And Second Quarter 2024 Results

Metagenomi Therapeutics

14/08/2024 13:45

Aug 14 (Reuters) - Metagenomi Inc  MGX.O :
    * METAGENOMI REPORTS BUSINESS UPDATES AND SECOND QUARTER
2024
FINANCIAL RESULTS
    * CASH RUNWAY ANTICIPATED TO SUPPORT OPERATING PLANS INTO
2027
    * TO ACCELERATE RELEASE OF DATA FROM 12-MONTH NHP DURABILITY
STUDY
FOR LEAD HEMOPHILIA A PROGRAM INTO SEPT 2024
    * QTRLY LOSS PER SHARE $0.29
    * LOOKING FOR A PARTNER OR LICENSEE FOR FURTHER DEVELOPMENT
OF ITS
PROGRAM FOR PRIMARY HYPEROXALURIA TYPE 1
    * NOT PURSUING ALS BASED ON RECENT PEER COMPANY CLINICAL
DATA
ABOUT LACK OF EFFICACY OF ATAXIN-2 AS THERAPEUTIC TARGET FOR ALS
    * ALL WAVE 1 IONIS COLLABORATION PROGRAMS ADVANCING IN LEAD
OPTIMIZATION, POTENTIAL FOR MULTIPLE DEVELOPMENT CANDIDATE
NOMINATIONS IN 2025

Source text for Eikon:  ID:nGNX4QnnF0 
Further company coverage:  MGX.O 

 ((Reuters.Briefs@thomsonreuters.com;))